LAVA Therapeutics
LVTX
LVTX
19 hedge funds and large institutions have $10.6M invested in LAVA Therapeutics in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
5% less funds holding
Funds holding: 20 → 19 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Holders
19
Holding in Top 10
3
Calls
$28K
Puts
–
Top Buyers
| 1 | +$61.8K | |
| 2 | +$35.7K | |
| 3 | +$18.8K | |
| 4 |
BCM
BML Capital Management
Zionsville,
Indiana
|
+$13.2K |
| 5 |
LDNAM
Lepercq De Neuflize Asset Management
New York
|
+$10.6K |
Top Sellers
| 1 | -$61.5K | |
| 2 | -$30.9K | |
| 3 | -$30.8K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$2.63K |
| 5 |
JPMorgan Chase & Co
New York
|
-$1.65K |
